S. Cheng, T. Sprong, L. Joosten, J. Van-der-meer, and B. Kullberg, Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs, European Journal of Immunology, vol.78, issue.4, pp.993-1004, 2012.
DOI : 10.1002/eji.201142057

W. Hu, X. Ge, T. You, T. Xu, and J. Zhang, Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis, Cancer Research, vol.71, issue.6, pp.2298-2307, 2011.
DOI : 10.1158/0008-5472.CAN-10-3016

L. Roumenina, D. Sène, M. Radanova, J. Blouin, and L. Halbwachs-mecarelli, Functional Complement C1q Abnormality Leads to Impaired Immune Complexes and Apoptotic Cell Clearance, The Journal of Immunology, vol.187, issue.8, pp.4369-4373, 2011.
DOI : 10.4049/jimmunol.1101749

M. Markiewski and J. Lambris, The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight, The American Journal of Pathology, vol.171, issue.3, pp.715-727, 2007.
DOI : 10.2353/ajpath.2007.070166

H. Muller-eberhard, Complement, Annual Review of Biochemistry, vol.38, issue.1, pp.389-414, 1969.
DOI : 10.1146/annurev.bi.38.070169.002133

H. Muller-eberhard, Molecular Organization and Function of the Complement System, Annual Review of Biochemistry, vol.57, issue.1, pp.321-347, 1988.
DOI : 10.1146/annurev.bi.57.070188.001541

S. Makrides, Therapeutic inhibition of the complement system, Pharmacol. Rev, vol.50, pp.59-87, 1998.

K. Hosszu, A. Valentino, Y. Ji, M. Matkovic, and L. Pednekar, Cell Surface Expression and Function of the Macromolecular C1 Complex on the Surface of Human Monocytes, Frontiers in Immunology, vol.3, p.38, 2012.
DOI : 10.3389/fimmu.2012.00038

G. Triolo, A. Accardo-palumbo, . Sall?-`-lsall?-`-sall?-`-l, F. Ciccia, and A. Ferrante, Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation, Clin. Exp. Rheumatol, vol.21, pp.225-228, 2003.

M. Gadjeva, S. Thiel, and J. Jensenius, The mannan-binding-lectin pathway of the innate immune response, Current Opinion in Immunology, vol.13, issue.1, pp.74-78, 2001.
DOI : 10.1016/S0952-7915(00)00185-0

J. Hodoniczky, Y. Zheng, and D. James, Control of Recombinant Monoclonal Antibody Effector Functions by Fc N-Glycan Remodeling in Vitro, Biotechnology Progress, vol.21, issue.6, pp.1644-1652, 2005.
DOI : 10.1021/bp050228w

P. Rudd, M. Wormald, and R. Dwek, Sugar-mediated ligand???receptor interactions in the immune system, Trends in Biotechnology, vol.22, issue.10, pp.524-530, 2004.
DOI : 10.1016/j.tibtech.2004.07.012

C. Jouault, S. Chevolot, L. Helley, D. Ratiskol, J. Bros et al., Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus, Biochim Biophys Acta, pp.141-51, 1528.

U. Nwodu, E. Green, and A. Okoh, Bacterial Exopolysaccharides: Functionality and Prospects, International Journal of Molecular Sciences, vol.13, issue.12, pp.14002-14015, 2012.
DOI : 10.3390/ijms131114002

T. Khalikova, T. Korolenko, S. Zhanaeva, V. Kaledin, and G. Kogan, Enhancing effect of new biological response modifier sulfoethylated (1?.3)- beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses, Exp. Oncol, vol.28, pp.308-313, 2006.

K. Okutani, Antitumor and immunostimulant activities of polysaccharide produced by a marine bacterium of the genus Vibrio., NIPPON SUISAN GAKKAISHI, vol.50, issue.6, pp.1035-1037, 1984.
DOI : 10.2331/suisan.50.1035

S. Makino, S. Ikegami, H. Kano, T. Sashihara, and H. Sugano, Immunomodulatory Effects of Polysaccharides Produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1, Journal of Dairy Science, vol.89, issue.8, pp.2873-81, 2006.
DOI : 10.3168/jds.S0022-0302(06)72560-7

A. Tzianabos, Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function, Clinical Microbiology Reviews, vol.13, issue.4, pp.523-533, 2000.
DOI : 10.1128/CMR.13.4.523-533.2000

P. Zanchetta, N. Lagarde, and J. Guezennec, Systemic Effects on Bone Healing of a New Hyaluronic Acid-Like Bacterial Exopolysaccharide, Calcified Tissue International, vol.73, issue.3, pp.232-236, 2003.
DOI : 10.1007/s00223-002-2081-7

P. Zanchetta, N. Lagarde, and J. Guezennec, A New Bone-Healing Material: A Hyaluronic Acid-Like Bacterial Exopolysaccharide, Calcified Tissue International, vol.72, issue.1, pp.74-79, 2003.
DOI : 10.1007/s00223-001-2091-x

S. Kwang-soon, Y. Kwang-won, L. Hyun-kyung, L. Ho, and C. Won-dai, Production of anti-complementary exopolysacharides from submerged culture of Flammulina velutipes, Food Technol. Biotechnol, vol.45, pp.319-326, 2007.

G. Raguénès, A. Peres, R. Ruimy, P. Pignet, and R. Christen, Alteromonas infernus sp. nov., a new polysaccharide-producing bacterium isolated from a deep-sea hydrothermal vent, Journal of Applied Microbiology, vol.82, issue.4, pp.422-430, 1997.
DOI : 10.1046/j.1365-2672.1997.00125.x

G. Raguénès, R. Christen, J. Guezennec, P. Pignet, and G. Barbier, Vibrio diabolicus sp. nov., a New Polysaccharide-Secreting Organism Isolated from a Deep-Sea Hydrothermal Vent Polychaete Annelid, Alvinella pompejana, International Journal of Systematic Bacteriology, vol.47, issue.4, pp.989-995, 1997.
DOI : 10.1099/00207713-47-4-989

B. Mulloy, P. Mourã-o, and E. Gray, Structure/function studies of anticoagulant sulphated polysaccharides using NMR, Journal of Biotechnology, vol.77, issue.1, pp.123-135, 2000.
DOI : 10.1016/S0168-1656(99)00211-4

H. Rougeaux, N. Kervarec, R. Pichon, and J. Guezennec, Structure of the exopolysaccharide of Vibriodiabolicus isolated from a deep-sea hydrothermal vent, Carbohydrate Research, vol.322, issue.1-2, pp.40-45, 1999.
DOI : 10.1016/S0008-6215(99)00214-1

O. Lowry, N. Rosebrough, A. Farr, and R. Randall, Protein measurement with the Folin phenol reagent, J Biol Chem, vol.193, pp.265-275, 1951.

Y. Lijour, E. Gentric, and E. Deslandes, Estimation of the Sulfate Content of Hydrothermal Vent Bacterial Polysaccharides by Fourier Transform Infrared Spectroscopy, Analytical Biochemistry, vol.220, issue.2, pp.244-248, 1994.
DOI : 10.1006/abio.1994.1334

A. Nardella, F. Chaubet, C. Boisson-vidal, C. Blondin, and P. Durand, Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum, Carbohydrate Research, vol.289, pp.201-208
DOI : 10.1016/0008-6215(96)00110-3

O. Maiga-revel, F. Chaubet, and J. Jozefonvicz, New investigations on heparinlike derivatized dextrans: CMDBS, synergistic role of benzylamide and sulfate substituents in anticoagulant activity. Carbohydr, Polymers, vol.32, pp.89-93, 1997.

H. Lutz, P. Stammler, E. Jelezarova, M. Nater, and P. Spä-th, High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes, Blood, vol.88, pp.184-193, 1996.

E. Caldwell, A. Andreasen, M. Blietz, J. Serrahn, and V. Vandernoot, Heparin Binding and Augmentation of C1 Inhibitor Activity, Archives of Biochemistry and Biophysics, vol.361, issue.2, pp.215-222, 1999.
DOI : 10.1006/abbi.1998.0996

U. Galili, The ??-gal epitope (Gal??1-3Gal??1-4GlcNAc-R) in xenotransplantation, Biochimie, vol.83, issue.7, pp.557-563, 2001.
DOI : 10.1016/S0300-9084(01)01294-9

A. Good, D. Cooper, A. Malcolm, and R. Ippolito, Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans, Transplant Proc, vol.24, pp.559-562, 1992.

C. Courtois, S. Gac-breton, C. Berthou, J. Guezennec, and . Bordron, Complement dependent cytotoxicity activity of therapeutic antibody fragments is acquired by immunogenic glycan coupling, Electron. J Biotechnol, vol.15, pp.1-11, 2012.

F. Yamamoto, Review: ABO blood group system?ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes, Immunohematol, vol.20, pp.3-22, 2004.

S. Vukajlovich, Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A, Infect. Immun, vol.53, pp.480-485, 1986.

F. Alberto, M. , G. Romero, D. Lazzari, M. Calabrese et al., Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate, Thrombosis Research, vol.122, issue.1, pp.109-116
DOI : 10.1016/j.thromres.2007.09.001

B. Tissot and R. Daniel, Letter to the Glyco-Forum: Biological properties of sulfated fucans: the potent inhibiting activity of algal fucoidan against the human complement system, Glycobiology, vol.13, issue.12, pp.29-30, 2003.
DOI : 10.1093/glycob/cwg126

C. Blondin, F. Chaubet, A. Nardella, C. Sinquin, and J. Jozefonvicz, Relationships between chemical characteristics and anticomplementary activity of fucans, Biomaterials, vol.17, issue.6, pp.597-603, 1996.
DOI : 10.1016/0142-9612(96)88710-2

M. Kirschfink, L. Blase, S. Engelmann, and R. Schwartz-albiez, Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1, J Immunol, vol.158, pp.1324-1331, 1997.

T. Jokiranta, J. Westin, U. Nilsson, B. Nilsson, and J. Hellwage, Complement C3b interactions studied with surface plasmon resonance technique, International Immunopharmacology, vol.1, issue.3, pp.495-506, 2001.
DOI : 10.1016/S1567-5769(00)00042-4

E. Caldwell, A. Andreasen, M. A. Blietz, J. Serrahn, and V. Vandernoot, Heparin Binding and Augmentation of C1 Inhibitor Activity, Archives of Biochemistry and Biophysics, vol.361, issue.2, pp.215-222, 1999.
DOI : 10.1006/abbi.1998.0996

J. Mcdonnell, Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition, Current Opinion in Chemical Biology, vol.5, issue.5, pp.572-577, 2001.
DOI : 10.1016/S1367-5931(00)00251-9